VIKING GLOBAL INVESTORS LP - Q2 2015 holdings

$26.5 Billion is the total value of VIKING GLOBAL INVESTORS LP's 56 reported holdings in Q2 2015. The portfolio turnover from Q1 2015 to Q2 2015 was 100.0% .

 Value Shares↓ Weighting
WBA BuyWALGREENS BOOTS ALLIANCE INC$2,079,345,000
+68.2%
24,625,113
+68.6%
7.86%
+64.0%
AGN NewALLERGAN PLC$2,064,752,0006,804,034
+100.0%
7.80%
GOOGL BuyGOOGLE INCcl a$1,477,632,000
+62.6%
2,736,152
+67.0%
5.58%
+58.5%
LYB BuyLYONDELLBASELL INDUSTRIES N$1,110,395,000
+63.9%
10,726,384
+39.0%
4.20%
+59.8%
VRX BuyVALEANT PHARMACEUTICALS INTL$1,025,608,000
+27.2%
4,616,738
+13.8%
3.88%
+24.1%
AMZN NewAMAZON COM INC$990,837,0002,282,561
+100.0%
3.74%
PXD BuyPIONEER NAT RES CO$886,403,000
-6.7%
6,391,252
+10.0%
3.35%
-9.0%
MET BuyMETLIFE INC$659,582,000
+95.8%
11,780,357
+76.8%
2.49%
+91.0%
MNKKQ BuyMALLINCKRODT PUB LTD CO$637,533,000
+42.3%
5,415,671
+53.1%
2.41%
+38.7%
AVGO NewAVAGO TECHNOLOGIES LTD$633,945,0004,769,014
+100.0%
2.40%
HUM BuyHUMANA INC$613,404,000
+149.6%
3,206,839
+132.3%
2.32%
+143.4%
GOOG BuyGOOGLE INCcl c$597,311,000
+29.6%
1,147,549
+36.4%
2.26%
+26.4%
EVHC BuyENVISION HEALTHCARE HLDGS IN$485,749,000
+84.9%
12,303,668
+79.6%
1.84%
+80.3%
CI NewCIGNA CORPORATION$472,200,0002,914,815
+100.0%
1.78%
CCI BuyCROWN CASTLE INTL CORP NEW$444,087,000
+18.2%
5,530,352
+21.5%
1.68%
+15.2%
CTRP BuyCTRIP COM INTL LTD$418,619,000
+69.1%
5,764,514
+36.5%
1.58%
+64.9%
AET NewAETNA INC NEW$394,820,0003,097,599
+100.0%
1.49%
ANTM NewANTHEM INC$312,966,0001,906,701
+100.0%
1.18%
WLL NewWHITING PETE CORP NEW$290,755,0008,653,431
+100.0%
1.10%
FOXA NewTWENTY FIRST CENTY FOX INCcl a$263,399,0008,093,383
+100.0%
1.00%
VRTX BuyVERTEX PHARMACEUTICALS INC$222,904,000
+6.7%
1,805,186
+2.0%
0.84%
+4.1%
RCPT BuyRECEPTOS INC$219,869,000
+40.2%
1,156,900
+21.6%
0.83%
+36.7%
BIIB NewBIOGEN INC$207,401,000513,444
+100.0%
0.78%
AMP NewAMERIPRISE FINL INC$201,730,0001,614,743
+100.0%
0.76%
AON BuyAON PLC$190,682,000
+132.4%
1,912,946
+124.1%
0.72%
+126.4%
CAR BuyAVIS BUDGET GROUP$190,442,000
+14.1%
4,320,377
+52.8%
0.72%
+11.3%
UHS NewUNIVERSAL HLTH SVCS INCcl b$173,468,0001,220,743
+100.0%
0.66%
MCK NewMCKESSON CORP$140,634,000625,568
+100.0%
0.53%
BLL NewBALL CORP$128,570,0001,832,789
+100.0%
0.49%
ESPR BuyESPERION THERAPEUTICS INC NE$114,064,000
+799.6%
1,395,107
+918.9%
0.43%
+779.6%
QUNR BuyQUNAR CAYMAN IS LTDspns adr cl b$108,496,000
+160.3%
2,531,989
+150.6%
0.41%
+154.7%
TDG NewTRANSDIGM GROUP INC$102,938,000458,176
+100.0%
0.39%
ALL NewALLSTATE CORP$92,977,0001,433,280
+100.0%
0.35%
COO NewCOOPER COS INC$48,686,000273,563
+100.0%
0.18%
KITE NewKITE PHARMA INC$41,297,000677,334
+100.0%
0.16%
ALXN NewALEXION PHARMACEUTICALS INC$36,471,000201,756
+100.0%
0.14%
DE NewDEERE & CO$25,231,000259,975
+100.0%
0.10%
PRQR BuyPROQR THRAPEUTICS N V$9,924,000
+11.1%
595,307
+45.8%
0.04%
+5.7%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2015-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
VISA INC36Q3 20237.0%
AMAZON COM INC34Q3 202310.6%
META PLATFORMS INC34Q3 202310.4%
MICROSOFT CORP30Q3 20239.1%
THERMO FISHER SCIENTIFIC INC29Q3 20235.4%
NETFLIX INC26Q2 20236.0%
MASTERCARD INCORPORATED25Q3 20233.9%
ELEVANCE HEALTH INC24Q2 202310.2%
ALPHABET INC22Q2 20219.3%
UNITEDHEALTH GROUP INC22Q3 20235.3%

View VIKING GLOBAL INVESTORS LP's complete holdings history.

Latest significant ownerships (13-D/G)
VIKING GLOBAL INVESTORS LP Q2 2015 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Celldex Therapeutics, Inc.Sold outFebruary 14, 202300.0%
Coupa Software IncSold outFebruary 14, 202300.0%
FIGS, Inc.Sold outFebruary 14, 202300.0%
Guardant Health, Inc.February 14, 20234,107,6444.0%
Orion Acquisition Corp.Sold outFebruary 14, 202300.0%
PROCEPT BioRobotics CorpSold outFebruary 14, 202300.0%
Frazier Lifesciences Acquisition CorpSold outNovember 25, 202200.0%
Cazoo Group LtdNovember 10, 202260,000,0007.3%
AbCellera Biologics Inc.Sold outFebruary 14, 202200.0%
Athira Pharma, Inc.Sold outFebruary 14, 202200.0%

View VIKING GLOBAL INVESTORS LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-15
32024-03-20
SC 13G/A2024-03-20
42024-03-07
42024-03-07
42024-03-01
42024-03-01
SC 13G/A2024-03-01
42024-02-28
42024-02-28

View VIKING GLOBAL INVESTORS LP's complete filings history.

Compare quarters

Export VIKING GLOBAL INVESTORS LP's holdings